2 treatment centers
No centers match
Try a different search term
2 SAMHSA-listed treatment centers in Scranton, Pennsylvania. Free, confidential help available 24/7 — most callers reach a licensed counselor in under 60 seconds.
Try a different search term
Scranton, Pennsylvania has 2 SAMHSA-verified addiction treatment centers offering a range of evidence-based programs. Pennsylvania consistently ranks among the top states for overdose deaths, particularly in Philadelphia and Pittsburgh.
Available programs in Scranton include 1 residential/inpatient rehab program, 1 outpatient program. All listed facilities are sourced directly from the federal SAMHSA National Registry of Substance Abuse Treatment Services.
Most treatment centers in Scranton accept Medicaid, Medicare, and major private insurance plans including Aetna, Cigna, BlueCross BlueShield, and UnitedHealthcare. Under the Affordable Care Act (ACA) and the Mental Health Parity Act, insurance providers are required to cover substance use disorder treatment at the same level as other medical conditions. Call (319) 271-2077 for a free insurance verification — no obligation, completely confidential.
When selecting from the 2 treatment options in Scranton, consider: the type and severity of the substance use disorder, whether co-occurring mental health conditions require dual diagnosis treatment, your insurance coverage and financial situation, the distance from home and your support network, and the facility's accreditation and evidence-based approach. Our helpline is available 24/7 at (319) 271-2077 to help match you with the right program — free and confidential.
Free, confidential assistance matching you with the right program in Scranton.
Treatment centers in Scranton accept most major insurance plans including Medicaid, Medicare, Blue Cross Blue Shield, Aetna, Cigna, and UnitedHealthcare. Many facilities also offer sliding scale fees and payment plans. Call (319) 271-2077 to verify your coverage before admission.
Most Scranton patients enter treatment at one of three levels: medically managed detox (if withdrawal risk warrants medical supervision), residential treatment (24-hour structured environment for those without stable recovery support at home), or intensive outpatient (9+ hours/week of programming for those able to maintain work/school and recover at home with structured support). The choice depends on ASAM criteria assessment performed by licensed clinicians, not solely on patient preference or insurance coverage limitations.
Same-day or rapid admission to Scranton programs is most often possible at facilities with rolling intake capacity, particularly during weekday business hours. Weekend admissions are increasingly common but require advance arrangement. Emergency department presentation with active overdose or severe withdrawal sometimes serves as a bridge to Scranton treatment entry — hospital case managers can coordinate transfer to residential treatment directly from ED, particularly for patients with insurance that covers acute stabilization plus subsequent residential.
Employment re-entry after addiction treatment is a Scranton priority that intersects with long-term recovery sustainability. The Americans with Disabilities Act protects employees in recovery from discrimination based on past substance use (current illegal use is not protected). FMLA may apply to treatment-related absences. State vocational rehabilitation services offer career counseling, education funding, and job placement support. Recovery-friendly employer initiatives are emerging in many U.S. markets including Pennsylvania.
Overdose response in Scranton: signs of opioid overdose include slowed or stopped breathing, blue lips or fingertips, pinpoint pupils, unconsciousness, and limp body. If you suspect overdose, call 911 immediately, administer naloxone (Narcan nasal spray is most common), perform rescue breathing or CPR if trained, and stay with the person until paramedics arrive. Pennsylvania Good Samaritan laws generally protect callers from prosecution for drug-related offenses when seeking emergency help, with specific protections varying by state.
Anxiety disorders complicate addiction recovery for many Scranton patients, particularly in early recovery when anxiety symptoms often intensify without the substance previously used to suppress them. Treatment approaches include cognitive-behavioral therapy specifically for anxiety, judicious psychiatric medication management (avoiding benzodiazepines for most patients in addiction recovery given the dependence risk), structured exposure work, mindfulness-based interventions, and lifestyle interventions (sleep, exercise, caffeine moderation) that compound the formal treatment effects.
Insurance coverage for addiction treatment in Scranton is governed by the Mental Health Parity and Addiction Equity Act (MHPAEA), which requires plans that cover substance-use treatment to do so at parity with medical/surgical benefits. In practice: if your plan covers a hospitalization for a heart condition, it must cover residential addiction treatment under comparable cost-sharing, day limits, and authorization requirements. The ACA further classifies substance-use disorder treatment as an Essential Health Benefit, meaning individual and small-group marketplace plans must include this coverage.
Treatment-seeking patients in Scranton navigate a continuum of substance-use care that includes ambulatory detox or medically managed inpatient withdrawal where clinically indicated, residential treatment for patients requiring 24-hour structure, partial hospitalization for those benefitting from intensive day programming, and outpatient counseling at lower intensities. The choice between these is rarely the patient's alone — clinical staff use ASAM Criteria documentation, insurance pre-authorization requirements, and patient-specific factors to recommend a placement that maximizes both safety and clinical effectiveness.